Sinovac Biotech (SVA) Total Current Liabilities (2009 - 2026)
Sinovac Biotech (SVA) recorded Total Current Liabilities of $1.09 billion in Q2 2026, down 78.2% from $5 billion a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Total Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech reported Total Current Liabilities of $1.54 billion, up 6.1% from FY2024.
- Annual Total Current Liabilities has increased for three straight years, with a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- Across earlier years, Total Current Liabilities came in at $1.45 billion in FY2024 (+12.3%), $1.29 billion in FY2023 (+2.9%), $1.26 billion in FY2022 (-50.1%) and $2.52 billion in FY2021 (+270.6%).
- The Q2 2026 figure is the lowest quarterly Total Current Liabilities since Q2 2022.
- On a year-over-year basis, Total Current Liabilities rose in three of the last four quarters, with growth averaging 68.6%.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 334.0% in Q2 2025, against a decline of 82.9% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 47.00 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 43.10 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.80 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -31.27 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 23.23 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 12.00 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 31.73 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Bn |
| Dec 31, 2025 | 1.54 Bn |
| Jun 30, 2025 | 5.00 Bn |
| Dec 31, 2024 | 1.45 Bn |
| Jun 30, 2024 | 1.15 Bn |
| Dec 31, 2023 | 1.29 Bn |
| Jun 30, 2023 | 1.19 Bn |
| Dec 31, 2022 | 1.26 Bn |
| Jun 30, 2022 | 564.86 Mn |
| Dec 31, 2021 | 2.52 Bn |
| Jun 30, 2021 | 3.31 Bn |
| Dec 31, 2020 | 679.61 Mn |
| Sep 30, 2020 | 193.86 Mn |
| Jun 30, 2020 | 113.52 Mn |
| Mar 31, 2020 | 81.29 Mn |
| Dec 31, 2019 | 87.20 Mn |
| Sep 30, 2019 | 74.27 Mn |
| Jun 30, 2019 | 69.82 Mn |
| Mar 31, 2019 | 56.55 Mn |
| Dec 31, 2018 | 58.21 Mn |
API Access
Sinovac Biotech Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();